Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T08:23:07.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Nitazoxanide in the treatment of Ascaris lumbricoides in a rural zone of Colima, Mexico

Published online by Cambridge University Press:  01 September 2007

M.L. Galvan-Ramirez ,
N. Rivera ,
M.E. Loeza ,
X. Avila ,
J. Acero ,
R. Troyo  and
R. Bernal
M.L. Galvan-Ramirez
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
N. Rivera
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
M.E. Loeza
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
X. Avila
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
J. Acero
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
R. Troyo
Affiliation:
Laboratorio de Fisiología, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
R. Bernal*
Affiliation:
Laboratorio de Parasitología y Micología, Hospital Infantil de Mexico Federico Gómez, >MéxicoD.F.
*
*Fax +52 5761 80 01 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Intestinal parasites in Mexico are an endemic problem. A study was conducted in children, teenagers and adults in a rural community in Colima, Mexico to examine the prevalence and intensity of Ascaris lumbricoides infection and to evaluate the parasitological and clinical efficacy of nitazoxanide (NTZ). Two hundred and eighty children, teenagers and adults participated in this study. Parasitological diagnosis from faeces was confirmed by three consecutive stool samples using the floatation concentration Faust method. Egg counts were performed as described by the Kato–Katz technique before and after treatment. A questionnaire was systematically applied to obtain information about socio-economic status and hygienic habits. One hundred and six participants (38%) were diagnosed as harbouring intestinal parasites, and 86 of them (81%) were infected with A. lumbricoides. All patients with ascariasis infections underwent a complete physical examination before and after NTZ treatment. NTZ resolved 88% of the ascariasis cases, with a 89% clinical efficacy, and there was a 97.5% reduction in the levels of morbidity. The most intense infections for A. lumbricoides were found in housewives, and statistically significant associations were found between ascariasis and the absence of drainage and living in houses with dirt floors.

Type
Research Papers
Information
Journal of Helminthology , Volume 81 , Issue 3 , September 2007 , pp. 255 - 259
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abaza, H., El-Zayali, A., Kabil, S.M. & Rizk, H. (1998) Nitazoxanide in the treatment of patients with intestinal protozoan and helmintic infections: a report on 546 patiens in Egypt. Current Therapeutic Research 59, 116–121.CrossRefGoogle Scholar
Amadi, B., Mwiya, M., Musuku, J., Watusu, A., Sianongo, S., Ayoub, A. & Kelly, P. (2002) Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360, 1375–1380.CrossRefGoogle ScholarPubMed
Cooperstock, M., DuPont, H., Corrado, M., Fekety, R. & Morgan, D. (1992) Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Giardia lamblia. Clinical Infectious Disease 15 (Suppl), 244–248.CrossRefGoogle ScholarPubMed
Dávila, C., Vasquez, C., Trujillo, B. & Huerta, M. (2002) Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. American Journal of Tropical Medicine and Hygiene 66, 251–254.CrossRefGoogle Scholar
Diaz, E., Mondragon, J., Ramirez, E. & Bernal, R. (2003) Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. American Journal of Tropical Medicine and Hygiene 68, 384–385.CrossRefGoogle ScholarPubMed
Doumbo, O., Rossignol, J.F., Pichard, E., Troare, H.A., Dembele, M., Diakite, M., Traore, F. & Diallo, D.A. (1999) Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infectious associated with acquired immunodeficiency syndrome in tropical Africa. American Journal Tropical Medicine and Hygiene 56, 637–639.CrossRefGoogle Scholar
Fox, L. & Saravolatz, L. (2005) Nitazoxanide: A new thiazolide antiparasitic agent. Clinical Infectious Disease 40, 1173–1179.CrossRefGoogle ScholarPubMed
Geerts, S. & Gryseels, B. (2000) Drug resistance in human helminths: Current situation on lessons from livestock. Clinical Microbiology Reviews 13, 207–222.CrossRefGoogle ScholarPubMed
Geets, S., Coles, G.C. & Gryseels, B. (1997) Anthelmintic resistance in human helminths: learning from the problem with worm control in livestock. Parasitology Today 13, 149–151.CrossRefGoogle Scholar
Gilles, H. & Hoffman, P. (2002) Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends in Parasitology 18, 95–97.CrossRefGoogle ScholarPubMed
Hall, A., Anwar, K.S. & Tomkins, M.A. (1992) Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 339, 1253–1257.CrossRefGoogle ScholarPubMed
INDRE (Instituto Nacional de Diagnóstico y Referencia Epidemiológicas) (1994) Encuestas centinelas para la evaluación de la eficacia de la quimioterapia masiva contra helmintos intestinales de octubre de 1993. México.Google Scholar
NCCLS (National Committee for Clinical Laboratory Standard) (1997) Procedures for the recovery and identification of parasites from intestinal tract. Approved Guideline. Pennsylvania, NCCLS.Google Scholar
Ortiz, J., Ayoub, A., Gargala, G., Chegne, N.L. & Favennec, L. (2001) Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Alimentary Pharmacology and Therapeutics 15, 1409–1415.CrossRefGoogle ScholarPubMed
Romero, C.R., Robert, G.L., Muñoz, G.R. & Geyne, C.A. (1997) Nitaxozanide in the treatment of patients with intestinal protozoan and helminthic infections in Mexico. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 701–703.Google Scholar
Rossignol, J. F. & Cavier, R. (1975) New derivative of 2-benzamido-5-nitrothiols. Chemical Abstracts 83, abstract 28216n.Google Scholar
Rossignol, J.F., Abaza, H. & Friedman, H. (1998) Successful treatment of human fascioliasis with nitazoxanide. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 103–104.CrossRefGoogle ScholarPubMed
Smith, H.M., DeKaminsky, R.G., Niwas, S., Soto, R.J. & Jolly, P.E. (2001) Prevalence and intensity of infections of Ascaris lumbricoides and Trichuris trichiura and associated socio-demographic variables in four rural Honduran communities. Memory Institute Oswaldo Cruz 96, 303–314.CrossRefGoogle ScholarPubMed
Torres, M., Flisser, A., Aguirre, M.T., Velasco, O., Mañon, M.L., Guzman, C., Dominguez, L., Gonzalez, G., Nava, M., del Rio, A., Garcia, L. & Valdespino, J.L. (2000) México. pp. 56–60 in OPS/OMS (Eds) Reunión sobre el control de las helmintiosis intestinales en el contexto de AIEPI. Rio de Janeiro, Brasil.Google Scholar
WHO (World Health Organization) (1987) Prevention and control of intestinal parasitic infections. Report of a WHO Expert Committee. Ginebra Technical Report Series 749: 1–86.Google Scholar
WHO (World Health Organization) (1996) Monitoring large-scale integrated control programmes: the Mexican experience. Report of the WHO informal consultation on the use of chemotherapy for the control of morbidity due to soil-transmitted nematodes in humans. WHO/CTD/SIP/96.2, pp. 32–36. Geneva, WHO.Google Scholar